Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-19

FDA Approved: DESVENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for desvenlafaxine from Sun Pharmaceutical Industries, updating the drug's approval in some manner through a supplem…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Desvenlafaxine (Desvenlafaxine)

Snippet

SUPPL AP for DESVENLAFAXINE (DESVENLAFAXINE)